본문 바로가기
KERD
논문KCI 등재

양성자 펌프 억제제 투여로 악화된 과증식 위용종 1예

A Case of Aggravated Hyperplastic Gastric Polyps after Treatment with Long-term Proton Pump Inhibitors

1

조회

0

다운로드

1

인용

0

참고문헌

키워드

주제분류의학일반

초록

Hyperplastic gastric polyps (HPPs) are the most common type of gastric polyps. They are assumed to be caused by chronic inflammation and regenerative proliferation, although this has not been clearly investigated yet. Many studies suggested the development of fundic gland polyps and carcinoid during long-term proton pump inhibitor (PPI) therapy, but the relationship between PPIs and HPPs is still unclear. We encountered a patient who showed aggravation of HPPs after long-term use of PPIs. A 58-year-old male patient with liver cirrhosis visited our hospital because of hematemesis. We started PPI medication after confirming esophageal variceal bleeding and duodenal ulcer with blood clot in its base via emergency endoscopy. He took PPIs for three years because of an intractable duodenal ulcer. There was a marked increase in the size of the pre-existing polyps and in the development of new polyps. We presumed that the PPIs caused the aggravation of the HPPs, so we stopped their administration. After five months, the HPPs shrank and the polyps were partially degraded. More prospective studies are needed to investigate the relationship between HPPs and PPIs.

Abstract

Hyperplastic gastric polyps (HPPs) are the most common type of gastric polyps. They are assumed to be caused by chronic inflammation and regenerative proliferation, although this has not been clearly investigated yet. Many studies suggested the development of fundic gland polyps and carcinoid during long-term proton pump inhibitor (PPI) therapy, but the relationship between PPIs and HPPs is still unclear. We encountered a patient who showed aggravation of HPPs after long-term use of PPIs. A 58-year-old male patient with liver cirrhosis visited our hospital because of hematemesis. We started PPI medication after confirming esophageal variceal bleeding and duodenal ulcer with blood clot in its base via emergency endoscopy. He took PPIs for three years because of an intractable duodenal ulcer. There was a marked increase in the size of the pre-existing polyps and in the development of new polyps. We presumed that the PPIs caused the aggravation of the HPPs, so we stopped their administration. After five months, the HPPs shrank and the polyps were partially degraded. More prospective studies are needed to investigate the relationship between HPPs and PPIs.

참고문헌 (15)

  1. Jain R, "Gastric hyperplastic polyps: a review", Dig Dis Sci, 54, pp.1839~1846 (2009)
  2. 강화미, "위 증식폴립의 종양전환에 관한 임상적 예측인자", 대한소화기학회지, 58(4), pp.184~189 (2011), 대한소화기학회
  3. Abraham SC, "Hyperplastic polyps of the stomach: associations with histologic patterns of gastritis and gastric atrophy", Am J Surg Pathol, 25, pp.500~507 (2001)
  4. Hongo M, "Incidence and risk factor of fundic gland polyp and hyperplastic polyp in long-term proton pump inhibitor therapy: a prospective study in Japan", J Gastroenterol, 45, pp.618~624 (2010)
  5. Choudhry U, "Proton pump inhibitor-associated gastric polyps: a retrospective analysis of their frequency, and endoscopic, histologic, and ultrastructural characteristics", Am J Clin Pathol, 110, pp.615~621 (1998)
  6. Lee SH, "A case of poorly differentiated adenocarcinoma arising from gastric hyperplastic polyp", Korean J Med, 77(Suppl 2), pp.S278~S281 (2009)
  7. Ji F, "Effect of drug treatment on hyperplastic gastric polyps infected with Helicobacter pylori: a randomized, controlled trial", World J Gastroenterol, 12, pp.1770~1773 (2006)
  8. Raghunath AS, "Review article:the long-term use of proton-pump inhibitors", Aliment Pharmacol Ther, 22(Suppl 1), pp.55~63 (2005)
  9. Thomson AB, "Safety of the long-term use of proton pump inhibitors", World J Gastroenterol, 16, pp.2323~2330 (2010)
  10. 김병욱, "장기간 위산분비억제제 투여가 혈청 가스트린, 크로모그라닌 A 및 그렐린의 발현에 미치는 영향", 대한소화기학회지, 53(2), pp.84~89 (2009), 대한소화기학회
  11. 박홍준, "위축성 위염 혹은 위암에 미치는 프로톤펌프억제제의 영향: Safe 측면", 대한내과학회지, 81(1), pp.1~5 (2011), 대한내과학회
  12. McCarthy DM, "Adverse effects of proton pump inhibitor drugs: clues and conclusions", Curr Opin Gastroenterol, 26, pp.624~631 (2010)
  13. Graham JR, "Gastric polyposis: onset during long-term therapy with omeprazole", Med J Aust, 157, pp.287~288 (1992)
  14. 김진수, "오메프라졸 투여 중지 후 저절로 사라진 다발 위저선 폴립 1예", 대한소화기학회지, 51(5), pp.305~308 (2008), 대한소화기학회
  15. Pashankar DS, "Gastric polyps and nodules in children receiving long-term omeprazole therapy", J Pediatr Gastroenterol Nutr, 35, pp.658~662 (2002)

관련 논문AI추천

Proton Pump Inhibitor-Related Gastric Mucosal Changes김광하거트앤리버 소화기연관학회협의회 · Gut and Liver2021 · 제15권 제5호The Clinicopathological Features of Gastric Hyperplastic Polyps with Neoplastic Transformations: A Suggestion of Indication for Endoscopic Polypectomy장동경, A-Reum Han, Byung-Hoon Min, Chang Ohk Sung, Cheol-Keun Park, Jae J. Kim, Jin Yong Kim, Jong Chul Rhee, Jun Haeng Lee, Kyoung Mee Kim, Poong-Lyul Rhee, Young-Ho Kim거트앤리버 소화기연관학회협의회 · Gut and Liver2009 · 제3권 제4호Magnified Endoscopic Findings of Multiple White Flat Lesions: A New Subtype of Gastric Hyperplastic Polyps in the StomachAkikazu Hirano, Akinori Iwashita, Atsuko Ota, Go Ikezono, Hiroshi Tanabe, Kenshi Yao, Kenta Chuman, Masaki Miyaoka, Rino Hasegawa, Seiji Haraoka, Shoutomi Ihara, Takao Kanemitsu, Toshiharu Ueki대한소화기내시경학회 · Clinical Endoscopy2018 · 제51권 제6호Proton pump inhibitor-induced fundic gland polyposis김광하, 박영주대한내과학회 · The Korean Journal of Internal Medicine2017 · 제32권 제1호과형성 위용종에서 발생한 위선암 2예강윤세, 김석현, 김연수, 성재규, 송규싱, 이병석, 정재훈, 정현용, 채경훈, 허원석대한소화기내시경학회 · Clinical Endoscopy2005 · 제31권 제6호Helicobacter pylori eradication reduces risk for recurrence of gastric hyperplastic polyp after endoscopic resection김태호, Hee Seok Moon, Jin Tae Jung, Sung Eun Kim, Su Youn Nam, Young Sin Cho대한내과학회 · The Korean Journal of Internal Medicine2023 · 제38권 제2호

이 간행물의 다른 논문 (18건)